Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 701–750 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
BTMDBiote Corp. Healthcare Nov 4 Sep '26 $43.0M −10.4% $0.0M −100.0% $0.01 −95.5% 5.7% −11.5 pp $44M
MCRBSeres Therapeutics, Inc. Healthcare Nov 4 Sep '26pending $0.6M† n/m — — — — — — $14M
ARAYAccuray Incorporated Healthcare Nov 4 Sep '26pending $86.5M† −8.0% — — — — — — $7M
APREAprea Therapeutics, Inc. Healthcare Nov 4 Sep '26pending — — — — — — — — $6M
AMGNAmgen Inc. Healthcare Nov 3 Sep '26 $10.37B +8.5% $3.86B +20.1% $7.08 +19.4% 35.8% +9.4 pp $247.7B
PFEPfizer, Inc. Healthcare Nov 3 Sep '26 $16.58B −0.4% $3.24B −8.4% $0.56 −9.7% 22.1% −11.1 pp $162.2B
TEVATeva Pharmaceutical Industries Limited Healthcare Nov 3 Sep '26 $4.39B −1.9% $233M −46.2% $0.20 −45.9% 16.3% −3.4 pp $49.7B
WATWaters Corporation Healthcare Nov 3 Sep '26 $1.77B +120.9% $81.0M −45.6% $0.82 −67.2% 7.2% −16.8 pp $44.2B
PHGKoninklijke Philips N.V. NY Registry Shares Healthcare Nov 3 Sep '26 $4.93B +1.5% — −85.3% $0.46 −84.2% 10.8% +3.1 pp $28.9B
RVTYRevvity, Inc. Healthcare Nov 3 Sep '26 $729M +4.3% $62.0M +31.9% $0.56 +40.0% 13.1% +1.3 pp $16.5B
MDGLMadrigal Pharmaceuticals, Inc. Healthcare Nov 3 Sep '26 $431M +50.2% $55.0M n/m $1.83 n/m 13.0% +52.7 pp $9.8B
HSICHenry Schein, Inc. Healthcare Nov 3 Sep '26 $3.47B +4.0% $119M +17.8% $1.06 +26.2% 6.2% +0.0 pp $9.2B
SYRESpyre Therapeutics, Inc. Healthcare Nov 3 Sep '26 $0.0M n/m −$96.0M n/m −$0.94 n/m — — $8.9B
RYTMRhythm Pharmaceuticals, Inc. Healthcare Nov 3 Sep '26 $92.0M +80.4% −$41.0M n/m −$0.61 n/m -42.6% +60.0 pp $8.1B
CORTCorcept Therapeutics Incorporated Healthcare Nov 3 Sep '26 $340M +63.5% $127M +535.0% $1.01 +531.3% 33.7% +28.8 pp $7.7B
ALKSAlkermes plc Healthcare Nov 3 Sep '26 $480M +21.8% $16.0M −80.7% $0.09 −81.6% 7.5% −15.1 pp $7.6B
AMRXAmneal Pharmaceuticals, Inc. Healthcare Nov 3 Sep '26 $863M +9.9% −$7.0M −450.0% −$0.06 −700.0% 11.1% +11.1 pp $7.4B
MIRMMirum Pharmaceuticals, Inc. Healthcare Nov 3 Sep '26 $186M +39.8% −$41.0M −1,467% −$0.62 −1,340% -32.2% −34.1 pp $6.0B
SHCSotera Health Company Healthcare Nov 3 Sep '26 $325M +4.5% $58.0M +20.8% $0.20 +17.6% 35.0% −0.7 pp $4.6B
STVNStevanato Group S.p.A. Healthcare Nov 3 Sep '26 $369M +6.9% — +16.7% $0.18 +23.1% 17.6% +0.2 pp $4.2B
TARSTarsus Pharmaceuticals, Inc. Healthcare Nov 3 Sep '26 $195M +63.9% −$668M n/m −$14.40 n/m -340.3% −328.1 pp $3.9B
DNLIDenali Therapeutics Inc. Healthcare Nov 3 Sep '26 $18.0M n/m $70.0M n/m $0.37 n/m -713.0% — $2.9B
ATRCAtriCure, Inc. Healthcare Nov 3 Sep '26 $154M +14.9% $4.0M n/m $0.08 n/m 2.8% +2.7 pp $2.8B
IDYAIDEAYA Biosciences, Inc. Healthcare Nov 3 Sep '26 $10.0M −95.2% −$126M −205.9% −$1.22 −191.7% — — $2.6B
UFPTUFP Technologies, Inc. Healthcare Nov 3 Sep '26 $172M +11.0% $21.0M +31.3% $2.64 +25.1% 16.0% +0.9 pp $2.3B
ADUSAddus HomeCare Corporation Healthcare Nov 3 Sep '26 $388M +7.2% $29.0M +26.1% $1.54 +24.2% 10.3% +1.2 pp $2.3B
BEAMBeam Therapeutics Inc. Healthcare Nov 3 Sep '26 $0.0M n/m −$134M n/m −$1.28 n/m — — $2.1B
ALMRAlamar Biosciences, Inc. Healthcare Nov 3 Sep '26 $34.0M — −$13.0M — −$0.19 — -45.1% — $2.1B
TRAXFirst Tracks Biotherapeutics, Inc. Healthcare Nov 3 Sep '26 $0.0M — −$31.0M — −$0.88 — — — $1.8B
RAREUltragenyx Pharmaceutical Inc. Healthcare Nov 3 Sep '26 $173M +8.1% −$118M n/m −$1.16 n/m -63.6% +43.3 pp $1.7B
INNVInnovAge Holding Corp. Healthcare Nov 3 Sep '26 $265M +12.3% $20.0M +150.0% $0.14 +133.3% 7.6% +4.1 pp $1.3B
AHCOAdaptHealth Corp. Healthcare Nov 3 Sep '26 $746M +23.7% −$154M −716.0% −$1.13 −806.2% -20.9% −32.0 pp $1.0B
CBLLCeriBell, Inc. Healthcare Nov 3 Sep '26 $29.0M +26.1% −$21.0M n/m −$0.55 n/m -70.0% −5.2 pp $1.0B
ARDXArdelyx, Inc. Healthcare Nov 3 Sep '26 $128M +16.4% −$1.0M n/m $0.00 n/m 3.1% −1.1 pp $799M
QDELQuidelOrtho Corporation Healthcare Nov 3 Sep '26 $619M −11.6% −$54.0M n/m −$0.78 n/m -1.2% +99.5 pp $677M
SOPHSOPHiA GENETICS SA Healthcare Nov 3 Sep '26 $24.0M +26.3% −$20.0M n/m −$0.24 n/m -73.5% +18.3 pp $634M
ZVRAZevra Therapeutics, Inc. Healthcare Nov 3 Sep '26pending $37.8M† +45.2% — — — — — — $559M
AQSTAquestive Therapeutics, Inc. Healthcare Nov 3 Sep '26 $8.0M −38.5% −$16.0M n/m −$0.13 n/m -191.5% −101.8 pp $465M
OCSOculis Holding AG Healthcare Nov 3 Sep '26pending $0.0M† n/m — — — — — — $464M
ARVNArvinas, Inc. Healthcare Nov 3 Sep '26pending $0.5M† −98.8% — — — — — — $447M
CTNMContineum Therapeutics, Inc. Healthcare Nov 3 Sep '26 $0.0M n/m −$19.0M n/m −$0.49 n/m — — $338M
FTHFaeth Therapeutics, Inc. Healthcare Nov 3 Sep '26 $0.0M n/m −$20.0M n/m −$0.79 n/m — — $233M
LABStandard BioTools Inc. Healthcare Nov 3 Sep '26 $19.0M −5.0% $13.0M n/m $0.03 n/m -102.0% +18.0 pp $213M
RXSTRxSight, Inc. Healthcare Nov 3 Sep '26pending $24.6M† −18.0% — — — — — — $203M
DTILPrecision BioSciences, Inc. Healthcare Nov 3 Sep '26 $0.0M n/m −$8.0M n/m −$0.28 n/m — — $197M
AMWLAmerican Well Corporation Healthcare Nov 3 Sep '26pending $49.0M† −12.5% — — — — — — $174M
IFRXInflaRx N.V. Healthcare Nov 3 Sep '26 — n/m — n/m −$0.02 n/m — — $169M
INMInMed Pharmaceuticals Inc. Healthcare Nov 3 Sep '26 $0.0M n/m −$2.33B n/m −$0.43 n/m — — $9M
VRTXVertex Pharmaceuticals Incorporated Healthcare Nov 2 Sep '26 $3.44B +11.9% $654M −39.6% $2.56 −39.0% 20.7% −17.8 pp $135.4B
IDXXIDEXX Laboratories, Inc. Healthcare Nov 2 Sep '26 $1.21B +9.9% $317M +15.3% $4.01 +17.9% 33.1% +1.0 pp $54.4B
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.